IL6 and COVID-19: In COVID-19 patients with acute respiratory distress syndrome (ARDS), ATII increases NOX and causes vasoconstriction and thrombosis via ROS, IL-6, tumour necrosis factor-Alpha (TNF-α), and other cytokines (Fig. 2) [25, 26].